Notable
R-2487-SS-01 · R-2487 · Sjogren's Syndrome (SS)
Primary completion pushed from Aug 30, 2028 to Aug 30, 2029
Also in this update: Study completion pushed from Aug 30, 2028 to Nov 30, 2029
Rise Therapeutics LLCPhase 1 NCT06297213 Registry history of NCT06297213 on ClinicalTrials.gov (opens the registry)